From Europe. For the global patent community.
Trending Topics:
JUVE Patent Healthcare

Healthcare

Cases
Cancer drug

BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe

The relatively unknown biotech company 2seventy bio has filed a lawsuit at the UPC against several Johnson & Johnson companies and Legend Biotech concerning the bone cancer therapy Carvykti. Brist ...

20 February 2026 by Mathieu Klos
Cases
Right to sue

No claim to damages for Millenium and Cilag in dispute over bortezomib

Millennium Pharma and its distributor Cilag are not eligible to receive damages from generic companies for the infringement of patents related to anti ...

19 February 2026 by Konstanze Richter
Cases
Unified Patent Court

Court of Appeal throws door to UPC wide open for litigation ensurers

In future, a litigation insurance policy will help claimants to secure securities for costs at the UPC. This is the result of yesterday's ruling by UP ...

19 February 2026 by Mathieu Klos
Sponsored Content Provisional Measures and Validity Assessment in the UPC: The Impact of Pending EPO Opposition

UPC Provisional Measures: Dual Validity Test When EPO Opposition Is Pending

The Unified Patent Court (UPC) has established a “more likely than not” standard for assessing patent validity in provisional measure proceedings, as ...

17 February 2026 by Simmons + Simmons LLP
Cases
Life sciences

Sophia Genetics and Bristows head off PI at local division Paris

The local division Paris has rejected a PI application filed by Guardant against Sophia Genetics. The biotech company had originally based its applica ...

29 January 2026 by Mathieu Klos
Cases
Unified Patent Court

Litigation insurers and funders follow first case of new Court of Appeal panel

The third panel of the UPC Court of Appeal hears its first case today in Syntorr vs Arthrex. The crucial issue of security for claimants is at stake. ...

26 January 2026 by Mathieu Klos
Cases
DNA sequencing

Illumina and Powell Gilbert in love with Lisbon

Illumina has taken its dispute with Element Biosciences over DNA sequencing technology to the UPC. Together with Powell Gilbert and the Portuguese law ...

21 January 2026 by Mathieu Klos
Cases
Supplementary protection certificates

CJEU to decide if authorisation for human drug precludes SPC for veterinary use

Can a veterinary product authorisation be considered the first market authorisation if the active ingredient was previously approved for human use? Th ...

20 January 2026 by Konstanze Richter
Cases
Cardiovascular care

AorticLab fends off infringement suit by US competitor Emboline

The local division Munich has ruled that Italian medical device manufacturer AorticLab does not infringe a patent held by its US competitor Emboline. ...

16 January 2026 by Christina Schulze
Cases
Cardiovascular drug

Novartis and Freshfields defend Entresto at Dutch Court of Appeal

Novartis has successfully defended against an attack on its SPC protecting a treatment for chronic heart failure in the Netherlands. The Court of Appe ...

12 January 2026 by Konstanze Richter
Cases
Blockbuster drug

Regional Court Munich grants PI to Regeneron against generics in Eylea case

Once again, Regeneron and Bayer have successfully defended their ophthalmic drug Eylea on the German market and beyond. Munich Regional Court yesterda ...

9 January 2026 by Konstanze Richter
Cases
Parkinson's drug

The Hague upholds sales ban on Vivanta's generic safinamide product

Vivanta is still barred from marketing its generic version of the Parkinson's treatment Xadago in the Netherlands. The District Court The Hague has up ...

5 January 2026 by Konstanze Richter
Sponsored Content Damages in the Unified Patent Court: Jurisdiction, Procedure, and Future Directions

The Unified Patent Court and Damages: Broad Powers, Procedural Flexibility, and the Road Ahead

The Unified Patent Court (UPC) is developing a reputation as an injunction-centric forum, but its broad powers and procedural flexibility for awarding ...

17 December 2025 by Simmons + Simmons LLP
Cases
Second medical use

Generics succeed against Sanofi over cancer drug cabazitaxel

Several generic drug companies scored a win at the UPC against Sanofi's second medical use patent for cabazitaxel. In a decision issued today, the loc ...

12 December 2025 by Konstanze Richter
Cases
MS drug

Boards of Appeal revoke Biogen's dosage patent for Tecfidera

The Boards of Appeal at the European Patent Office have refused to grant Biogen's dosage patent EP 873, which is central to its multiple sclerosis dru ...

12 December 2025 by Mathieu Klos
Cases
Cancer drug

Halozyme and Quinn Emanuel secure PI against MSD over Keytruda SC

Merck Sharp & Dohme cannot launch Keytruda SC in Germany following a preliminary injunction issued by Munich Regional Court. Halozyme has thus pre ...

8 December 2025 by Mathieu Klos
Popular